IL5 and chronic rhinosinusitis with nasal polyps: Other promising immunomodulatory therapies for CRSwNP include anti-IL-5 therapeutics like reslizumab and mepolizumab [54], which target IL-5, a pivotal player in eosinophil maturation and activation, crucial components of CRSwNP's inflammatory response.